Definitive Contract HHSF223201710063C
Award Date 9/18/17
Potential Completion Date 9/29/22
Potential Value $1.9M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20857, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract awarded by the Food and Drug Administration (FDA) to the Commonwealth of Virginia State Board of Health Office of Epidemiology Division, doing business as Office of Epidemiology-Central Office. The contract has a ceiling value of $371,732.40 and is a definitive, firm fixed-price contract. The contract period of performance is from September 30, 2015 to September 29, 2016, with one option period. The contract is not set aside. The contract provides for services...
- This is a $456,571.04 firm-fixed-price federal contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to the Virginia State Board of Health's Office of Emergency Preparedness, doing business as the Emergency Preparedness & Response Programs. This is a fee-for-service contract with a final completion date of September 29, 2022. It does not have a set-aside designation. The available...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...
- This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...
- This contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the Colorado Department of Public Health & Environment, a state government entity, to provide mammography equipment inspections in Denver, Colorado. The contract is a definitive, firm-fixed price award with a potential value of $1,038,055.94 and a completion date of June 30, 2022. The contract does not have a set-aside designation. As a state health department, the Colorado Department of...
- This is a sole-source federal contract awarded by the Food and Drug Administration (FDA) to the State of North Carolina Department of Health & Human Services (NC DHHS) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has a ceiling value of $2,548,801.45 and a period of performance ending on September 29, 2027. This is a Firm Fixed Price contract with no...
- This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
- This is a $501,949.66 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health to conduct inspections of mammography facilities in Rhode Island under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of January 14, 2028. The Rhode Island Department of Health, a U.S. state government entity, will be the prime contractor delivering these inspection services. This contract award is not associated...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price, definitive contract valued at one hundred thirty-nine thousand, nine hundred thirty dollars and two cents ($139,930.02) to the Hawaii Department of Health for mammography inspection services in Honolulu, Hawaii. As the prime contractor, the Hawaii Department of Health will perform inspections under the contract through its Children With Special Health Needs - Newborn Screening division. The...
- This is a federal contract award by the Food and Drug Administration (FDA) to the Ohio Department of Health (ODH) to conduct inspections of certified non-federal mammography facilities in Ohio and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract is a five-year, Firm Fixed Price award with a ceiling value of $1,928,987.04. The contract does not have a set-aside designation. The original solicitation indicates that the FDA is awarding...